Cell subset frequency and TREC content of the patient and control populations
. | Control (n = 28) . | Early RA (n = 26) . | Resistant RA (n = 32) . |
---|---|---|---|
Naive CD4+ T cells* | 11 (3.85-25.6) | 1.50 (0.15-12.8) | 3.7 (0.28-10.3) |
Memory CD4+ T cells* | 44 (15-61) | 36 (15-53) | 35 (12-68) |
Atypical RBbright CD4+ T cells* | 2.5 (0.1-7.5) | 10.2 (1.0-33) | 14 (5-40) |
Total TREC (% cells)† | 4.77 (1.5-10.85) | 0.82 (0.01-6.40) | 1.85 (0.33-4.7) |
Naive TREC (% cells)† | 8.0 (2.68-17.4) | 4.70 (0.47-8.96) | 1.77 (0.09-7.24) |
. | Control (n = 28) . | Early RA (n = 26) . | Resistant RA (n = 32) . |
---|---|---|---|
Naive CD4+ T cells* | 11 (3.85-25.6) | 1.50 (0.15-12.8) | 3.7 (0.28-10.3) |
Memory CD4+ T cells* | 44 (15-61) | 36 (15-53) | 35 (12-68) |
Atypical RBbright CD4+ T cells* | 2.5 (0.1-7.5) | 10.2 (1.0-33) | 14 (5-40) |
Total TREC (% cells)† | 4.77 (1.5-10.85) | 0.82 (0.01-6.40) | 1.85 (0.33-4.7) |
Naive TREC (% cells)† | 8.0 (2.68-17.4) | 4.70 (0.47-8.96) | 1.77 (0.09-7.24) |